Tenzing TZACU = 1C, 1W

extend meeting ....  from September 28, 2020 to December 28, 2020 
9:00 a.m. Thursday, September 24, 2020. - vote and submit your questions during the special meeting... https://www.cstproxy.com/tenzingacquisitioncorp/​sms2020. 

Reviva Presentation 7-30-20

​No minimum cash requirement.

S4 -8/12/20 - The per share redemption price will be approximately $10.78 at the closing of the Business Combination.

Tenzing announces Reviva Pharm

424B4 8/22/18

Warrant 1 + $11.50. Call $21.

​Trust $10.20 ~ $56.1mm.  JP Morgan. Continental Trustee.

5.5 million units.

Deadline 18 months. Closed August 23, 2018 . Expire Feb 23 2020. 

Focus India.


 In connection with the Extension Proposal, shareholders of the Ordinary Shares (“Public Shares”) sold in the Company’s initial public offering elected to redeem 2,534,624 Public Shares, which represents approximately 44% of the Public Shares that were outstanding as of April 24, 2020, the record date of the Special Meeting. Following such redemptions, approximately $34,008,726.92 will remain in the trust account, without taking into account the additional $0.066 for each Public Share that is not redeemed to be deposited into the trust account, and 3,194,490 Ordinary Shares will remain issued and outstanding.


Extend meeting --- May 21, 2020. Trust 10.64
 to extend the date by which Tenzing must consummate a business combination (the “Extension”) from May 26, 2020 (or June 23, 2020 if the Company has executed a definitive agreement for a business combination by May 26, 2020) to July 27, 2020 (or September 28, 2020 if the Company has executed a definitive agreement for a business combination by July 27, 2020) ​So extended 1 month plus 3 with definitive. Close maybe?

If the Extension Proposal is approved, our sponsor, or its designees, has agreed to contribute to us as a loan (i) $.066 for each public share that is not redeemed (the “Initial Contribution”) in connection with the special meeting plus (ii) $ .033 for each public share that is not redeemed for each subsequent calendar month commencing on July 27, 2020, and on the 28th day of each subsequent month, or portion thereof, that is needed by Tenzing to complete an initial business combination from July 27, 2020 until the Extended Date (the “Additional Contributions” and, collectively with the Initial Contribution, the “Contributions”). For example, if Tenzing takes until September 28, 2020 to complete its business combination, which would represent four calendar months, our sponsor or its designees would make aggregate maximum Contributions of approximately $0.132 per share (assuming no public shares were redeemed). Assuming the Extension Proposal is approved, the Initial Contribution will be deposited in the trust account promptly following the special meeting. Each Additional Contribution will be deposited in the trust account within nineteen calendar days from the beginning of such calendar month (or portion thereof). Accordingly, if the Extension Proposal is approved and the Extension is implemented and the Company takes the full time through the Extended Date to complete the initial business combination, the redemption amount per share at the meeting for such business combination or the Company’s subsequent liquidation will be approximately $10.772 per share, in comparison to the current redemption amount of $10.64 per share (assuming no public shares were redeemed).  

 Tenzing estimates that the per-share pro rata portion of the trust account will be approximately $10.64 at the time of the special meeting.

A total of $56,100,000, comprised of $52,862,500 of the proceeds from the IPO and $3,237,500 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental 




Notwithstanding the foregoing, if a registration statement covering the issuance of the ordinary shares issuable upon exercise of the public warrants is not effective within 90 days following the consummation of our initial business combination, public warrant holders may, until such time as there is such an effective registration statement and during any period when we shall have failed to maintain such an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. 

Parag Saxena, our Chairman, has been part of direct investments in companies that have created hundreds of thousands of jobs and that have an aggregate market value exceeding $500 billion as of June 2018 in a career spanning over 30 years. Mr. Saxena is a multi-year member of Forbes’ Midas list, which ranks the World’s best technology investors. He has a strong track record in raising capital and successful investments in both public and private markets around the world. In addition, he has served on committees advising the Prime Minister of India on foreign direct investments and the Planning Commission of India on venture capital.
Our Chief Executive Officer, Rahul Nayar, has worked in capital markets for over 20 years, including with global financial institutions such as GE Capital and UBS, and independently since 2007. He has significant experience and relationships within the private equity industry in India. For over 10 years, he has provided consulting services to one of the largest independent global managers of secondary private equity and co-investment funds with total capital of approximately $38 billion and to Indian companies interested in accessing the US capital markets. He previously advised on an Indian IPO in the US and worked with various U.S. SPAC management teams on sourcing Indian transactions. We expect these relationships and experiences to be valuable for deal sourcing.
Our Chief Financial Officer, Gonzalo Cordova, has been Senior and Lead Portfolio Manager of over $900 million in structured finance vehicles, including a collateralized financial obligations of private equity holdings and collateralized bond obligations of emerging market collateral. In a career spanning over 30 years, he has also served as director of a hedge fund, managed global balanced and fixed income funds and portfolios, served as Investment Counselor specializing in emerging markets and derivatives transactions, and has been a member of various investment policy and asset allocation committees, including committees having responsibility for evaluation and selection of private equity funds as well as private companies.
Our Vice President, Atanuu Agarrwal, has worked closely on $700 million in assets across the U.S. and the Indian subcontinent, including in the early stage, growth capital and buyout asset classes and diverse sectors like financial services, education, telecom, pharmaceutical, healthcare, SAAS and media.